KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 126 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 0.61 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $38,000 | -20.8% | 11,217 | -11.5% | 0.00% | – |
| Q2 2018 | $48,000 | -4.0% | 12,671 | +4.1% | 0.00% | – |
| Q1 2018 | $50,000 | -30.6% | 12,171 | -20.9% | 0.00% | – |
| Q4 2017 | $72,000 | -26.5% | 15,387 | +11.7% | 0.00% | – |
| Q3 2017 | $98,000 | -6.7% | 13,772 | -5.0% | 0.00% | – |
| Q2 2017 | $105,000 | -31.4% | 14,491 | -41.8% | 0.00% | – |
| Q1 2017 | $153,000 | +118.6% | 24,901 | +109.2% | 0.00% | – |
| Q4 2016 | $70,000 | -9.1% | 11,905 | -17.6% | 0.00% | – |
| Q3 2016 | $77,000 | -6.1% | 14,442 | +17.3% | 0.00% | – |
| Q2 2016 | $82,000 | +41.4% | 12,314 | -1.7% | 0.00% | – |
| Q1 2016 | $58,000 | -76.8% | 12,526 | -36.2% | 0.00% | -100.0% |
| Q1 2015 | $250,000 | +1.6% | 19,624 | +12.9% | 0.00% | 0.0% |
| Q4 2014 | $246,000 | – | 17,389 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Old West Investment Management, LLC | 1,068,719 | $3,633,000 | 1.50% |
| Abrams Capital Management | 9,108,867 | $30,970,000 | 0.82% |
| Baupost Group | 25,791,678 | $87,692,000 | 0.67% |
| Bristol Advisors, LLC | 51,100 | $174,000 | 0.29% |
| RICE HALL JAMES & ASSOCIATES, LLC | 2,228,059 | $7,575,000 | 0.27% |
| NEXTHERA CAPITAL LP | 200,000 | $680,000 | 0.13% |
| LINCOLN CAPITAL CORP | 37,280 | $127,000 | 0.10% |
| Meridian Wealth Management, LLC | 49,600 | $169,000 | 0.07% |
| Rubric Capital Management LP | 199,883 | $680,000 | 0.07% |
| Virtus ETF Advisers LLC | 155,009 | $527,000 | 0.05% |